Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 976 - 1000 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA06
  • Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Gb3(d18:1/26:0)
 44260169 75188 1163.827069 C62H117NO18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ06
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Isoglobotriglycosylceramide(d18:1/26:0)
 44261569 73269 1163.827069 C62H117NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA06
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261945 1163.827069 C62H117NO18
LMSL03001276
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R-hexamethyl)-13-O-hydroxy-octacosanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/28:0(2Me[S],4Me[S],6Me[S],8Me[R],10Me[R],12Me[R],13OH))
 126457717 1166.808977 C62H118O17S
Gangliosides LMSP0601DH03
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44262614 1167.749214 C59H109NO21
Diacylglycerophosphoinositolglycans LMGP15010095
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:2(9Z,12Z))
 126457463 1168.615833 C56H97O23P
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA01
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261852 1169.728479 C58H107NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ01
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261620 1169.728479 C58H107NO22
Diacylglycerophosphoinositolglycans LMGP15010089
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:2(9Z,12Z))
 126457457 1170.631483 C56H99O23P
Diacylglycerophosphoinositolglycans LMGP15010094
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:1(9Z))
 126457462 1170.631483 C56H99O23P
Diacylglycerophosphoinositolglycans LMGP15010083
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:2(9Z,12Z))
 126457451 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010088
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:1(9Z))
 126457456 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010093
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:2(9Z,12Z)/16:0)
 126457461 1172.647133 C56H101O23P
Diacylglycerophosphoinositolglycans LMGP15010061
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:1(9Z))
 126457429 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010082
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:1(9Z))
 126457450 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010087
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:0)
 126457455 1174.662783 C56H103O23P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA07
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • asialo-GM2(d18:1/24:1(15Z))
 44260490 1174.806668 C62H114N2O18
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA07
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Lc3Cer(d18:1/24:1(15Z))
 44260618 1174.806668 C62H114N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA07
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44261954 1174.806668 C62H114N2O18
Diacylglycerophosphoinositolglycans LMGP15010060
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:0)
 126457428 1176.678433 C56H105O23P
Diacylglycerophosphoinositolglycans LMGP15010081
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:0/16:0)
 126457449 1176.678433 C56H105O23P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA05
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • asialo-GM2(d18:1/24:0)
 44260488 1176.822318 C62H116N2O18
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA05
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • Lc3Cer(d18:1/24:0)
 44260616 1176.822318 C62H116N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA05
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261952 1176.822318 C62H116N2O18
Gangliosides LMSP0601AJ02
  • GM3(d18:1/18:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262037 84675 1180.744463 C59H108N2O21
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024